retatrutide and tirzepatide together vs — What to Know Before You Decide Issuu

GLP-1 (Glucagon-like peptide-1) receptor agonists are a class of medications initially developed to treat type 2 diabetes

Choi IY, Lee JS, Kim JK, et al

This was the first head-to-head comparison, published in the New England Journal of Medicine

Semaglutide, when combined with a balanced diet and regular physical activity, can result in significant weight loss

Many people assume GLP-1 drugs will deliver dramatic, lasting weight loss on their own

In Figure 4AC, we plot how the percentage of obese US adults could decrease if a fixed annual supply of semaglutide was administered in 2.4 mg doses to either (1) a proportion of obese US adults at q1wk dosing (termed scenario (1)) or (2) twice as many obese US adults at q2wk dosing (termed scenario (2))